Tiny Bubbles Offer New Hope in Cancer Fight

Nanoparticle innovations like extracellular vesicles and liposomes are transforming cancer treatment

Jan. 27, 2026 at 10:15pm

Advancements in nanotechnology, specifically the manipulation of microscopic bubbles called extracellular vesicles and their artificial counterparts, liposomes, are revolutionizing the fight against cancer. Recent research suggests these tiny particles aren't just how cancer spreads, but potentially how we can stop it. Liposomes are becoming sophisticated drug delivery systems, allowing for targeted treatment that minimizes side effects. Beyond drugs, liposomes are also being explored as vectors for gene therapy and immunotherapy, offering new avenues for personalized cancer care.

Why it matters

Understanding the mechanisms behind metastasis, the spread of cancer to other parts of the body, is crucial as it is responsible for approximately 90% of cancer-related deaths. Nanoparticle technologies like liposomes provide researchers with powerful tools to study this process and develop more effective, targeted treatments.

The details

Extracellular vesicles (EVs), released by both healthy and cancerous cells, act as messengers, carrying genetic material that can transform healthy cells into cancerous ones. Researchers are now creating artificial EVs, called liposomes, to precisely control their size, charge, and composition in order to observe how they interact with cancer cells. Early results show that mimicking the natural vesicle's properties dramatically increases absorption by cancer cells. Liposomes can also be engineered to deliver drugs directly to tumor cells, minimizing side effects and maximizing efficacy. This targeted approach is already showing promise in clinical trials. Liposomes are also being explored as vectors for gene therapy and immunotherapy, offering new avenues for personalized cancer care.

  • Researchers have published studies on liposome-based cancer treatments in journals like Scientific Advances and Frontiers in Nutrition.

The players

École de technologie supérieure (ÉTS)

A university in Montreal, Canada that is conducting research on nanoparticle technologies for cancer treatment.

McGill University Health Centre

A medical research institution in Montreal, Canada that is collaborating on studies related to extracellular vesicles and liposomes for cancer metastasis.

Got photos? Submit your photos here. ›

What’s next

Researchers are exploring innovative manufacturing techniques, such as using microfluidic devices and 3D printing, to create liposomes with unprecedented precision and control. The integration of artificial intelligence (AI) and machine learning algorithms will further accelerate the development of personalized nanomedicines.

The takeaway

Nanoparticle technologies like extracellular vesicles and liposomes are revolutionizing cancer treatment by providing new tools to study metastasis and develop more targeted, personalized therapies. These innovations hold immense promise in the fight against this devastating disease.